Therapeutic Application of Hydrogels for Bone-related Diseases

Overview

Journal Front Bioeng Biotechnol

Date 2022 Sep 29

PMID 36172014

Authors

Xiyu Liu

Shuoshuo Sun

Nan Wang

Ran Kang

Lin Xie

Xin Liu

Affiliations

Soon will be listed here.

Abstract

Bone-related diseases caused by trauma, infection, and aging affect people's health and quality of life. The prevalence of bone-related diseases has been increasing yearly in recent years. Mild bone diseases can still be treated with conservative drugs and can be cured confidently. However, serious bone injuries caused by large-scale trauma, fractures, bone tumors, and other diseases are challenging to heal on their own. Open surgery must be used for intervention. The treatment method also faces the problems of a long cycle, high cost, and serious side effects. Studies have found that hydrogels have attracted much attention due to their good biocompatibility and biodegradability and show great potential in treating bone-related diseases. This paper mainly introduces the properties and preparation methods of hydrogels, reviews the application of hydrogels in bone-related diseases (including bone defects, bone fracture, cartilage injuries, and osteosarcoma) in recent years. We also put forward suggestions according to the current development status, pointing out a new direction for developing high-performance hydrogels more suitable for bone-related diseases.

Citing Articles

Stimuli-responsive hydrogels for bone tissue engineering.

Xue C, Chen L, Wang N, Chen H, Xu W, Xi Z Biomater Transl. 2024; 5(3):257-273.

PMID: 39734705 PMC: 11681187. DOI: 10.12336/biomatertransl.2024.03.004.

Exosome-Laden Hydrogels as Promising Carriers for Oral and Bone Tissue Engineering: Insight into Cell-Free Drug Delivery.

Villani C, Murugan P, George A Int J Mol Sci. 2024; 25(20).

PMID: 39456873 PMC: 11508290. DOI: 10.3390/ijms252011092.

Hydrogel Use in Osteonecrosis of the Femoral Head.

Bal Z, Takakura N Gels. 2024; 10(8).

PMID: 39195073 PMC: 11353442. DOI: 10.3390/gels10080544.

Biofabrication of functional bone tissue: defining tissue-engineered scaffolds from nature.

Rifai A, Weerasinghe D, Tilaye G, Nisbet D, Hodge J, Pasco J Front Bioeng Biotechnol. 2023; 11:1185841.

PMID: 37614632 PMC: 10444209. DOI: 10.3389/fbioe.2023.1185841.

Mechanical stimulation promotes MSCs healing the lesion of intervertebral disc annulus fibrosus.

Deng R, Kang R, Jin X, Wang Z, Liu X, Wang Q Front Bioeng Biotechnol. 2023; 11:1137199.

PMID: 36845186 PMC: 9950411. DOI: 10.3389/fbioe.2023.1137199.

References

Wheeler T, Sbravati N, Janorkar A . Mechanical & cell culture properties of elastin-like polypeptide, collagen, bioglass, and carbon nanosphere composites. Ann Biomed Eng. 2013; 41(10):2042-55. DOI: 10.1007/s10439-013-0825-3. View

Polat G, Ersen A, Erdil M, Kizilkurt T, Kilicoglu O, Asik M . Long-term results of microfracture in the treatment of talus osteochondral lesions. Knee Surg Sports Traumatol Arthrosc. 2016; 24(4):1299-303. DOI: 10.1007/s00167-016-3990-8. View

Obata A, Ogasawara T, Kasuga T . Combinatorial effects of inorganic ions on adhesion and proliferation of osteoblast-like cells. J Biomed Mater Res A. 2019; 107(5):1042-1051. DOI: 10.1002/jbm.a.36623. View

Hochberg M . Osteoarthritis year 2012 in review: clinical. Osteoarthritis Cartilage. 2012; 20(12):1465-9. DOI: 10.1016/j.joca.2012.07.022. View

Zhang W, Moskowitz R, Nuki G, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16(2):137-62. DOI: 10.1016/j.joca.2007.12.013. View

Preethi Soundarya S, Haritha Menon A, Chandran S, Selvamurugan N . Bone tissue engineering: Scaffold preparation using chitosan and other biomaterials with different design and fabrication techniques. Int J Biol Macromol. 2018; 119:1228-1239. DOI: 10.1016/j.ijbiomac.2018.08.056. View

Al-Samadi A, Adnan Awad S, Tuomainen K, Zhao Y, Salem A, Parikka M . Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in and models. Oncotarget. 2017; 8(36):60123-60134. PMC: 5601126. DOI: 10.18632/oncotarget.17768. View

Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z . Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B. 2021; 11(4):941-960. PMC: 8105778. DOI: 10.1016/j.apsb.2020.12.018. View

Wang X, Kluge J, Leisk G, Kaplan D . Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials. 2007; 29(8):1054-64. PMC: 2693043. DOI: 10.1016/j.biomaterials.2007.11.003. View

10.

Nikravesh N, Borchard G, Hofmann H, Philipp E, Fluhmann B, Wick P . Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice. Nanomedicine. 2020; 26:102178. DOI: 10.1016/j.nano.2020.102178. View

11.

Mehrotra D, Dwivedi R, Nandana D, Singh R . From injectable to 3D printed hydrogels in maxillofacial tissue engineering: A review. J Oral Biol Craniofac Res. 2020; 10(4):680-689. PMC: 7549114. DOI: 10.1016/j.jobcr.2020.09.006. View

12.

Zhang Z, Jia B, Yang H, Han Y, Wu Q, Dai K . Zn0.8Li0.1Sr-a biodegradable metal with high mechanical strength comparable to pure Ti for the treatment of osteoporotic bone fractures: In vitro and in vivo studies. Biomaterials. 2021; 275:120905. DOI: 10.1016/j.biomaterials.2021.120905. View

13.

Kolambkar Y, Dupont K, Boerckel J, Huebsch N, Mooney D, Hutmacher D . An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials. 2010; 32(1):65-74. PMC: 3013370. DOI: 10.1016/j.biomaterials.2010.08.074. View

14.

Hilkens C, Isaacs J . Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?. Clin Exp Immunol. 2013; 172(2):148-57. PMC: 3628318. DOI: 10.1111/cei.12038. View

15.

Hamblin T, Curtis S, DAstous J, Aoki S . Childhood obesity and low-velocity knee dislocation in a fifteen-year-old girl: a case report. J Bone Joint Surg Am. 2010; 92(12):2216-9. DOI: 10.2106/JBJS.J.00115. View

16.

Zhang Y, Khademhosseini A . Advances in engineering hydrogels. Science. 2017; 356(6337). PMC: 5841082. DOI: 10.1126/science.aaf3627. View

17.

Su C, Liu Y, Li R, Wu W, Fawcett J, Gu J . Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems. Adv Drug Deliv Rev. 2019; 143:97-114. DOI: 10.1016/j.addr.2019.06.008. View

18.

Patel M, Patel K, Caccamese J, Coletti D, Sauk J, Fisher J . Characterization of cyclic acetal hydroxyapatite nanocomposites for craniofacial tissue engineering. J Biomed Mater Res A. 2010; 94(2):408-18. DOI: 10.1002/jbm.a.32683. View

19.

Bao W, Li M, Yang Y, Wan Y, Wang X, Bi N . Advancements and Frontiers in the High Performance of Natural Hydrogels for Cartilage Tissue Engineering. Front Chem. 2020; 8:53. PMC: 7028759. DOI: 10.3389/fchem.2020.00053. View

20.

Chen Q, Liu S, Yuan Z, Yang H, Xie R, Ren L . Construction and Tribological Properties of Biomimetic Cartilage-Lubricating Hydrogels. Gels. 2022; 8(7). PMC: 9319379. DOI: 10.3390/gels8070415. View